<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01135602</url>
  </required_header>
  <id_info>
    <org_study_id>THoPA-O</org_study_id>
    <nct_id>NCT01135602</nct_id>
  </id_info>
  <brief_title>Topiramate for Hospitalized Patients With Alcoholism: a 12-week Study</brief_title>
  <acronym>THoPA-O</acronym>
  <official_title>Topiramate for Hospitalized Patients With Alcoholism: a 12-Week Open-Label Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiang Mai University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiang Mai University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      12-week, open-label study of topiramate in hospitalized patients with alcoholism&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">March 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognition</measure>
    <time_frame>12 weeks</time_frame>
    <description>Cognition will be assessed by the use of Montreal Cognitive Assessment (MoCA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alcohol drink/day</measure>
    <time_frame>12 weeks</time_frame>
    <description>Alcohol drink/day assessed by the use of Timeline Followback (TLFB)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Alcohol Dependence</condition>
  <arm_group>
    <arm_group_label>Topiramate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topiramate</intervention_name>
    <description>Topiramate 50-300 mg/day Orally Twice per day</description>
    <arm_group_label>Topiramate</arm_group_label>
    <other_name>Topamax</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients hospitalized due to alcohol-related problems&#xD;
&#xD;
          -  DSM-IV-TR alcohol dependence&#xD;
&#xD;
          -  &gt;/= 35 drinks/week (male) or &gt;/= 28 drinks/week (female) for &gt;/= 1 week during four&#xD;
             weeks prior to the admission&#xD;
&#xD;
          -  AUDIT score &gt;/= 8&#xD;
&#xD;
          -  Mild or no alcohol withdrawal&#xD;
&#xD;
          -  Body mass index &gt; 18 kg/m2&#xD;
&#xD;
          -  No pregnancy and no plan for pregnancy (female)&#xD;
&#xD;
          -  Intention to decrease or stop drinking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe psychiatric and cognitive disorders&#xD;
&#xD;
          -  Other substance dependence, except nicotine and caffeine dependence, during 6 months&#xD;
             prior to enrollment&#xD;
&#xD;
          -  Taking antipsychotics, mood stabilizers, anticonvulsants, opioid analgesics,&#xD;
             systematic steroids, carbonic anhydrase inhibitors, hydrochlorthiazide, metformin,&#xD;
             pioglitazone, or disulfiram&#xD;
&#xD;
          -  Moderate to high risk of suicide&#xD;
&#xD;
          -  Medical history of narrow angle glaucoma, renal impairment, kidney stones, and&#xD;
             seizures&#xD;
&#xD;
          -  Unstable medical conditions&#xD;
&#xD;
          -  Plan to receive a formal treatment for alcoholism from other treatment settings&#xD;
&#xD;
          -  Under legal process&#xD;
&#xD;
          -  Pregnancy and nursing woman&#xD;
&#xD;
          -  Abnormal laboratory tests, including blood urea nitrogen, creatinine, electrolytes,&#xD;
             and fasting blood sugar&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manit Srisurapanont, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry, Faculty of Medicine, Chiang Mai University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manit Srisurapanont, MD</last_name>
    <phone>6653945422</phone>
    <email>msrisu@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maharaj Nakorn Chiang Mai Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chiang Mai</state>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manit Srisurapanont, MD</last_name>
      <phone>6653945422</phone>
      <email>msrisu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Pichai Sangchanchai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maharaj Nakorn Chiang Mai Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chiang Mai</state>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manit Srisurapanont, MD</last_name>
      <phone>+66-53-945422</phone>
      <email>msrisu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Manit Srisurapanont, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <study_first_submitted>June 2, 2010</study_first_submitted>
  <study_first_submitted_qc>June 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2010</study_first_posted>
  <last_update_submitted>August 12, 2011</last_update_submitted>
  <last_update_submitted_qc>August 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Manit Srisurapanont</name_title>
    <organization>Department of Psychiatry, Faculty of Medicine, Chiang Mai University</organization>
  </responsible_party>
  <keyword>Alcohol dependence</keyword>
  <keyword>Alcoholism</keyword>
  <keyword>Topiramate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Topiramate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>July 21, 2014</submitted>
    <returned>August 11, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

